Literature DB >> 7617533

A compartmental model for the ocular pharmacokinetics of cyclosporine in rabbits.

C Oh1, B A Saville, Y L Cheng, D S Rootman.   

Abstract

Studies were conducted in rabbits to determine the ocular distribution and elimination of cyclosporine, with the objective of developing a comprehensive pharmacokinetic model. Following a bolus dose into the anterior chamber, drug levels were measured in the aqueous humor, cornea, iris/ciliary body, lens, sclera, and conjunctiva. Cyclosporine was rapidly eliminated from the aqueous, but drug levels in ocular tissues persisted for in excess of 48 hours, particularly in the cornea and iris/ciliary body. The terminal elimination half life from these tissues was 45 hr and 30 hr, respectively, providing evidence that these tissues could act as a reservoir for the drug. It was found that a compartmental model accurately described the experimental data. A single compartment was used for each of the tissues and fluids sampled, except for the cornea, which was subdivided into two compartments, representing its tissue and aqueous regions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7617533     DOI: 10.1023/a:1016268922035

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  Intraocular penetration of topically applied cyclosporine.

Authors:  R L Kaswan
Journal:  Transplant Proc       Date:  1988-04       Impact factor: 1.066

2.  Liquid-chromatographic determination of cyclosporin A in blood and plasma.

Authors:  R J Sawchuk; L L Cartier
Journal:  Clin Chem       Date:  1981-08       Impact factor: 8.327

3.  Cyclosporin A: tissue levels following topical and systemic administration to rabbits.

Authors:  T A Bell; A G Hunnisett
Journal:  Br J Ophthalmol       Date:  1986-11       Impact factor: 4.638

4.  Ocular pharmacokinetics of subconjunctivally administered cyclosporine in the rabbit.

Authors:  G S Kalsi; G Gudauskas; N Bussanich; D J Freeman; J Rootman
Journal:  Can J Ophthalmol       Date:  1991-06       Impact factor: 1.882

5.  Penetration of 2% cyclosporin eyedrops into human aqueous humour.

Authors:  M Diaz-Llopis; J L Menezo
Journal:  Br J Ophthalmol       Date:  1989-08       Impact factor: 4.638

6.  The pharmacokinetics of cyclosporine. I. Single dose and constant rate infusion studies in the rabbit.

Authors:  W M Awni; R J Sawchuk
Journal:  Drug Metab Dispos       Date:  1985 Mar-Apr       Impact factor: 3.922

7.  Pharmacokinetic of topical cyclosporin A in the rabbit eye.

Authors:  M Wiederholt; D Kössendrup; W Schulz; F Hoffmann
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-04       Impact factor: 4.799

8.  Ocular penetration of cyclosporin A. III: The human eye.

Authors:  D BenEzra; G Maftzir; C de Courten; P Timonen
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

Review 9.  Recent advances in cyclosporine pharmacokinetics.

Authors:  G C Yee
Journal:  Pharmacotherapy       Date:  1991       Impact factor: 4.705

Review 10.  Clinical pharmacokinetics in organ transplant patients.

Authors:  R Venkataramanan; K Habucky; G J Burckart; R J Ptachcinski
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447

View more
  4 in total

1.  General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.

Authors:  Feng Deng; Veli-Pekka Ranta; Heidi Kidron; Arto Urtti
Journal:  Pharm Res       Date:  2016-07-18       Impact factor: 4.200

2.  Pharmacokinetics of vancomycin following intracameral bolus injection in patients undergoing phacoemulsification cataract surgery.

Authors:  Conor C Murphy; Steven Nicholson; Say Aun Quah; Mark Batterbury; Timothy Neal; Stephen B Kaye
Journal:  Br J Ophthalmol       Date:  2007-03-27       Impact factor: 4.638

3.  Cyclosporin A in the ocular fluids of uveitis patients following long-term systemic administration.

Authors:  Paolo Mora; Uta Ceglarek; Francesca Manzotti; Laura Zavota; Arturo Carta; Raffaella Aldigeri; Jelka G Orsoni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-05-06       Impact factor: 3.117

4.  Pharmacokinetics of intracameral voriconazole injection.

Authors:  Ying-Cheng Shen; Mei-Yen Wang; Chun-Yuan Wang; Tsun-Chung Tsai; Hin-Yeung Tsai; Hsin-Nung Lee; Li-Chen Wei
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.